Skip to main content

Table 2 Gamma Irradiation Therapy (IR) and Electromagnetic Field Therapy (TEMF) on Blood Counts(Means ± SEM)

From: Therapeutic Electromagnetic Field (TEMF) and gamma irradiation on human breast cancer xenograft growth, angiogenesis and metastasis

Therapy Group

n

WBC × 103/μL

RBC × 106/μL

Platelets × 103/μL

Micronuclei (%RBC)

Early 1

     

Control

4

2.91 ± 0.83

9.08 ± 0.07

584 ± 76

1.3 ± 0.04

IR

4

0.11 ± 0.01

7.50 ± 0.16

389 ± 17

1.2 ± 0.03

TEMF

5

2.89 ± 0.60

9.05 ± 0.12

505 ± 61

1.3 ± 0.04

TEMF/IR

4

0.23 ± 0.06

7.68 ± 0.13

443 ± 34

1.2 ± 0.03

Late 2

     

Control

8

1.85 ± 0.37

8.30 ± 0.14

551 ± 83

1.6 ± 0.06

IR

13

1.48 ± 0.332

7.06 ± 0.16

973 ± 98

0.7 ± 0.01

TEMF

11

1.15 ± 0.29

8.85 ± 0.22

613 ± 62

0.7 ± 0.01

TEMF/IR

10

1.07 ± 0.13

6.58 ± 0.11

1007 ± 141

0.6 ± 0.01

  1. 1Mice sacrificed one day after last irradiation treatment.
  2. 2Mice sacrificed 22 days after last irradiation treatment.
  3. Results of Statistical Analyses:
  4. 1. At the end of irradiation therapy plus one day, gamma irradiation caused significant decreases in WBC, RBC, and platelet counts. No other significant differences at p < 0.01.
  5. 2. At the end of irradiation therapy plus 22 days, gamma irradiation caused significant decreases in WBC and RBC counts and a significant increase in platelet counts. No other significant differences at p < 0.01.
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us